PEARRL's Dr. Rene Holm (Jannsen) recently published a review in Advanced Drug Delivery Reviews highlighting the importance of joint academia-industry research consortia, such as PEARRL, for advancing innovation in the pharmaceutical drug development field. Dr. Holm gives examples of where academia and industry have successfully collaborated withing large multi-partner networks to produce major advances in scientific understanding and novel drug delivery technologies. He also highlights the importance that all stakeholders in the the Pharmaceutical ecosystem (figure insert), including academia, industry, CRO's, service/technology providers, etc., are involved in such consortia, so that new technological advances meets the needs of the various stakeholders, including patients, regulators and industry. Finally he emphasizes the need that future funding calls for similar academic-industry consortia focusing on addressing 'gaps in academic research and the needs of industrial product development' and sharing the data so all stakeholders can benefit. The full article can be accessed here R. Holm, Bridging the gaps between academic research and industrial product developments ..., Adv.Drug Deliv. Rev., https://doi.org/10.1016/j.addr.2019.01.009
RSS Feed
